Dr. Deborah Geraghty

COO, Anokian S.A.

Cambridge, MA


Geraghty is currently responsible for business and corporate development at Anokian. Previously, she was SVP of corporate strategy at Dimension Therapeutics and was responsible for driving gene therapy portfolio growth, and helped lead to the acquisition of the company by Ultragenyx Pharmaceutical Inc. She was a founder and VP  of project and portfolio development at Cydan Development, an orphan drug accelerator.

  • October 2020

Added to: ReAlta Life Sciences Inc. - Norfolk, VA

ReAlta Life Sciences is an early-stage biotech company dedicated to harnessing the power of the immune system to address life-threatening medical needs. It has developed a novel class of drugs with unique multi-modal therapeutic capabilities that rebalance complement and inflammatory processes.